American Heart Journal
Volume 158, Issue 5 , Pages 713-718 , November 2009

Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST)

  • Willem Dewilde, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Willem Dewilde, MD, Sint Antonius Hospital, Nieuwegein, The Netherlands, Koekoekslaan 1, 3435 CM Nieuwegein.
    • ,
  • Jurriën Ten Berg, MD, PhD, FACC

Received 14 February 2009 ,Accepted 11 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 RCT no. NCT00769938.

PII: S0002-8703(09)00718-2

doi: 10.1016/j.ahj.2009.09.001

American Heart Journal
Volume 158, Issue 5 , Pages 713-718 , November 2009

Article Tools

* Image Usage & Resolution